Related references
Note: Only part of the references are listed.A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women
Howard A. Crystal et al.
ADDICTION BIOLOGY (2012)
The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review
Lara A. Ray et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
A common single nucleotide polymorphism A118G of the mu opioid receptor alters its N-glycosylation and protein stability
Peng Huang et al.
BIOCHEMICAL JOURNAL (2012)
Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression
Francesco Leri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The genetics of the opioid system and specific drug addictions
Orna Levran et al.
HUMAN GENETICS (2012)
Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats
Elena Chartoff et al.
NEUROPHARMACOLOGY (2012)
Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment
O. Levran et al.
PHARMACOGENOMICS JOURNAL (2012)
Dose escalation and dose preference in extended-access heroin self-administration in Lewis and Fischer rats
Roberto Picetti et al.
PSYCHOPHARMACOLOGY (2012)
Pharmacogenetics of alcohol, nicotine and drug addiction treatments
Jessica E. Sturgess et al.
ADDICTION BIOLOGY (2011)
Involvement of Arginine Vasopressin and V1b Receptor in Alcohol Drinking in Sardinian Alcohol-Preferring Rats
Yan Zhou et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Haplotype block structure of the genomic region of the mu opioid receptor gene
Orna Levran et al.
JOURNAL OF HUMAN GENETICS (2011)
A genetic determinant of the striatal dopamine response to alcohol in men
V. A. Ramchandani et al.
MOLECULAR PSYCHIATRY (2011)
Persistent Increase in Hypothalamic Arginine Vasopressin Gene Expression During Protracted Withdrawal from Chronic Escalating-Dose Cocaine in Rodents
Yan Zhou et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response
Francina Fonseca et al.
PLOS ONE (2011)
Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients
Chin-Chuan Hung et al.
PHARMACOGENOMICS (2011)
β-Arrestin2 influences the response to methadone in opioid-dependent patients
B. Oneda et al.
PHARMACOGENOMICS JOURNAL (2011)
Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: Strain and heroin effects
S. D. Schlussman et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment
Vadim Yuferov et al.
ADDICTION REVIEWS 2 (2010)
OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models
Stephen D. Mague et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction
Ishani Deb et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes
Francina Fonseca et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size
Joern Loetsch et al.
PHARMACOGENETICS AND GENOMICS (2010)
Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity
Agnieszka Gieryk et al.
PSYCHOPHARMACOLOGY (2010)
Biological pathways and genetic variables involved in pain
Qiuling Shi et al.
QUALITY OF LIFE RESEARCH (2010)
Response to Corticotropin-Releasing Hormone Infusion in Cocaine-Dependent Individuals
Kathleen T. Brady et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain
Francesco Leri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain
Bruno Georg Oertel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Behavioral and Neurochemical Changes Induced by Oxycodone Differ Between Adolescent and Adult Mice
Yong Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2009)
MU OPIOID RECEPTOR KNOCKDOWN IN THE SUBSTANTIA NIGRA/VENTRAL TEGMENTAL AREA BY SYNTHETIC SMALL INTERFERING RNA BLOCKS THE REWARDING AND LOCOMOTOR EFFECTS OF HEROIN
Y. Zhang et al.
NEUROSCIENCE (2009)
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution
Alexandra Doehring et al.
PHARMACOGENETICS AND GENOMICS (2009)
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior
Stephen D. Mague et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Predictors of Treatment Outcome in Outpatient Cocaine and Alcohol Dependence Treatment
Jamshid Ahmadi et al.
AMERICAN JOURNAL ON ADDICTIONS (2009)
Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
Nitya Jayaram-Lindstrom et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Role of a functional human gene polymorphism in stress responsivity and addictions
M. J. Kreek
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
BDNF variability in opioid addicts and response to methadone treatment:: preliminary findings
R. de Cid et al.
GENES BRAIN AND BEHAVIOR (2008)
Genetic susceptibility to heroin addiction: a candidate gene association study
O. Levran et al.
GENES BRAIN AND BEHAVIOR (2008)
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
Orna Levran et al.
HUMAN MOLECULAR GENETICS (2008)
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction
D. A. Nielsen et al.
MOLECULAR PSYCHIATRY (2008)
The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice
Paul Marquez et al.
PSYCHOPHARMACOLOGY (2008)
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Van A. Redila et al.
PSYCHOPHARMACOLOGY (2008)
Involvement of arginine vasopressin and VIb receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin
Yan Zhou et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Population-specific effects 14OAsp polymorphism at the μ-opioid receptor gene of the As (OPRM1) on HPA-axis activation
Carlos A. Hernandez-Avila et al.
PHARMACOGENETICS AND GENOMICS (2007)
Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis
Stephen J. Glatt et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Downregulation of κ-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose Binge cocaine administration paradigm
Alexis Bailey et al.
SYNAPSE (2007)
Stress, dysregulation of drug reward pathways, and the transition to drug dependence
George Koob et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at μ, δ, and κ opioid receptors
Xuemei Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population
Dandan Zhang et al.
BIOLOGICAL PSYCHIATRY (2007)
Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal
Yan Zhou et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain
Francesco Leri et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Association between two μ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
HP Zhang et al.
HUMAN MOLECULAR GENETICS (2006)
Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes
R Sinha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients
E Peles et al.
JOURNAL OF ADDICTIVE DISEASES (2006)
Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats
PM Beardsley et al.
PSYCHOPHARMACOLOGY (2005)
Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues
HC Fox et al.
PSYCHONEUROENDOCRINOLOGY (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Persistent Upregulation of μ-opioid, but not adenosine, receptors in brains of long-term withdrawn escalating dose Binge cocaine-treated rats
A Bailey et al.
SYNAPSE (2005)
Endogenous κ-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine
VI Chefer et al.
JOURNAL OF NEUROSCIENCE (2005)
Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists
BT Zhu
BIOMEDICINE & PHARMACOTHERAPY (2005)
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments
MJ Kreek et al.
PHARMACOLOGICAL REVIEWS (2005)
Neurobiology of craving, conditioned reward and relapse
F Weiss
CURRENT OPINION IN PHARMACOLOGY (2005)
Increased attributable risk related to a functional μ-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden
G Bart et al.
NEUROPSYCHOPHARMACOLOGY (2005)
DHEAS and POMS measures identify cocaine dependence treatment outcome
JN Wilkins et al.
PSYCHONEUROENDOCRINOLOGY (2005)
Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: Evidence for opioid receptor modulation
Y Zhou et al.
NEUROSCIENCE (2005)
Effect of the endogenous κ opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice
Y Zhang et al.
PSYCHOPHARMACOLOGY (2004)
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
ID Montoya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden
G Bart et al.
MOLECULAR PSYCHIATRY (2004)
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor
A Beyer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine
Y Zhou et al.
MOLECULAR BRAIN RESEARCH (2003)
Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ-opioid receptor locus (OPRM1)
CA Hernandez-Avila et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal
Y Zhou et al.
BRAIN RESEARCH (2003)
Effect of chronic Binge cocaine on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice
Y Zhang et al.
SYNAPSE (2003)
Pharmacotherapy of addictions
MJ Kreek et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
G Griebel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis
SS O'Malley et al.
PSYCHOPHARMACOLOGY (2002)
The Mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade
GS Wand et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice
Y Zhang et al.
BRAIN RESEARCH (2001)
Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction
JH Schluger et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Ethanol consumption and reward are decreased in μ-opiate receptor knockout mice
FS Hall et al.
PSYCHOPHARMACOLOGY (2001)
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Y Shaham et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
